Telesis Bio Management
Management criteria checks 2/4
Telesis Bio's CEO is Eric Esser, appointed in Jun 2022, has a tenure of 2.42 years. total yearly compensation is $683.56K, comprised of 62.2% salary and 37.8% bonuses, including company stock and options. directly owns 0.015% of the company’s shares, worth $243.05. The average tenure of the management team and the board of directors is 2.2 years and 0.3 years respectively.
Key information
Eric Esser
Chief executive officer
US$683.6k
Total compensation
| CEO salary percentage | 62.2% |
| CEO tenure | 2.4yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.2yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
The Market Lifts Telesis Bio, Inc. (NASDAQ:TBIO) Shares 38% But It Can Do More
Apr 17
Codex DNA GAAP EPS of -$0.50, revenue of $5.7M; raises FY22 guidance
Aug 09Codex DNA, Inc. (NASDAQ:DNAY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This Space
Jan 06Codex: Synthetic DNA/mRNA Instrument Developer Holds Impressive Upside In 2021
Sep 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$47m |
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$47m |
| Dec 31 2023 | US$684k | US$425k | -US$49m |
Compensation vs Market: Eric's total compensation ($USD683.56K) is about average for companies of similar size in the US market ($USD649.07K).
Compensation vs Earnings: Insufficient data to compare Eric's compensation with company performance.
CEO
Eric Esser (56 yo)
2.4yrs
Tenure
US$683,564
Compensation
Mr. Eric Esser serves as President of Telesis Bio, Inc. since May 1, 2023 and serves as its CEO & Director since April 18, 2024. He serves as Chief Operating Officer at Telesis Bio, Inc. (formerly known as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.4yrs | US$683.56k | 0.015% $ 243.0 | |
| Chief Financial Officer | 1.3yrs | no data | no data | |
| Chief Technology Officer | 6.3yrs | US$1.33m | 0.29% $ 4.7k | |
| Vice President of Investor Relations | 1.9yrs | no data | no data | |
| Senior Vice President of Corporate Development | no data | no data | no data | |
| Director of Investor Relations | no data | no data | no data |
2.2yrs
Average Tenure
56yo
Average Age
Experienced Management: TBIO's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$683.56k | 0.015% $ 243.0 | |
| Independent Director | 1.1yrs | US$254.30k | 0% $ 0 | |
| Independent Director | 3.5yrs | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data |
0.3yrs
Average Tenure
56yo
Average Age
Experienced Board: TBIO's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.